Literature DB >> 12006339

Autoantibodies against C1q: view on association between systemic lupus erythematosus disease manifestation and C1q autoantibodies.

D Monova, S Monov, K Rosenova, T Argirova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12006339      PMCID： PMC1754130          DOI： 10.1136/ard.61.6.563

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  C1q complement component and -antibodies reflect SLE activity and kidney involvement.

Authors:  P Horák; Z Hermanová; J Zadrazil; H Ciferská; M Ordeltová; L Kusá; M Zurek; T Tichý
Journal:  Clin Rheumatol       Date:  2005-11-26       Impact factor: 2.980

2.  Anti-C1q autoantibodies in murine lupus nephritis.

Authors:  L A Trouw; M A Seelen; R Visseren; J M G J Duijs; H Benediktsson; E de Heer; A Roos; C van Kooten; M R Daha
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

3.  C1q and anti-C1q antibody levels are correlated with disease severity in Chinese pediatric systemic lupus erythematosus.

Authors:  Feng Qi Wu; Qing Zhao; Xiao Dai Cui; Wei Zhang
Journal:  Rheumatol Int       Date:  2009-12-23       Impact factor: 2.631

4.  Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus.

Authors:  Olivier C Meyer; Pascale Nicaise-Roland; Nolwenn Cadoudal; Sabine Grootenboer-Mignot; Elisabeth Palazzo; Gilles Hayem; Philippe Dieudé; Sylvie Chollet-Martin
Journal:  Arthritis Res Ther       Date:  2009-06-10       Impact factor: 5.156

5.  Clinical utility of anti-C1q antibody in primary and secondary vasculitic conditions.

Authors:  Kabeerdoss Jayakanthan; And Nikhil Gupta; John Mathew; Raheesh Ravindran; Gowri Mahasampth; Debashish Danda
Journal:  Int J Health Sci (Qassim)       Date:  2017 Nov-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.